These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 3922731

  • 1. [Acute liver necrosis caused by valproate].
    Zäh W, Rengeling M, Rühl G, Hackenberg K.
    Dtsch Med Wochenschr; 1985 Jun 14; 110(24):956-9. PubMed ID: 3922731
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A suspected case of late-onset sodium-valproate-induced hepatic failure.
    van Egmond H, Degomme P, de Simpel H, Dierick AM, Roels H.
    Neuropediatrics; 1987 May 14; 18(2):96-8. PubMed ID: 3110642
    [Abstract] [Full Text] [Related]

  • 5. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M, Abramson RK.
    Ann Pharmacother; 2005 Dec 14; 39(12):2119-23. PubMed ID: 16288075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT, Burcet J, Ramió L, Ustrell X, Silva Y, Molins A.
    Neurologia; 2003 Dec 14; 18(6):347-50. PubMed ID: 12838456
    [Abstract] [Full Text] [Related]

  • 10. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S, Bakhiet M, Khan A, Sequeira R.
    Neuro Endocrinol Lett; 2006 Dec 14; 27(1-2):85-8. PubMed ID: 16648782
    [Abstract] [Full Text] [Related]

  • 11. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure.
    Triggs WJ, Gilmore RL, Millington DS, Cibula J, Bunch TS, Harman E.
    Int J Clin Pharmacol Ther; 1997 Sep 14; 35(9):353-6. PubMed ID: 9314085
    [Abstract] [Full Text] [Related]

  • 12. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE.
    Epilepsy Behav; 2007 Jun 14; 10(4):583-7. PubMed ID: 17412645
    [Abstract] [Full Text] [Related]

  • 13. [Fatal hepatic necrosis during treatment with sodium valproate].
    Miguil M, Chlihi A, Mjahed K, Sarf I, Moutawakkil S, Benaguida M.
    Cah Anesthesiol; 1995 Jun 14; 43(3):325-6. PubMed ID: 7583902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests.
    Dewan P, Aggarwal A, Faridi MM.
    Indian Pediatr; 2008 Oct 14; 45(10):855-8. PubMed ID: 18948659
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S, Carcas A, Piñana E, Ortega R.
    J Clin Pharm Ther; 2006 Aug 14; 31(4):393-6. PubMed ID: 16882111
    [Abstract] [Full Text] [Related]

  • 19. [Alterations of the state of consciousness induced by valproic acid: 6 case reports].
    Campostrini R, Paganini M, Boncinelli L, Zaccara G, Arnetoli G, Zappoli R.
    Riv Patol Nerv Ment; 1983 Aug 14; 104(1):23-34. PubMed ID: 6431599
    [Abstract] [Full Text] [Related]

  • 20. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA, Schenk M, Sick C, Holm E, Heubner C, Weiss A, König I, Hehlmann R.
    Epilepsia; 1999 Jul 14; 40(7):1036-40. PubMed ID: 10403231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.